Survodutide 10mg
$54.99
In stock
Join the Zark Discord
Get product updates, restock alerts, support, giveaways, and wishlist requests all in one place.
Survodutide is an investigational once-weekly dual agonist medication targeting glucagon and GLP-1 receptors. Developed by Boehringer Ingelheim and Zealand Pharma, it is currently undergoing Phase III clinical trials for weight management and liver disease.
Only logged in customers who have purchased this product may leave a review.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Related products
Reviews
There are no reviews yet.